6515--Purchase of a Molecular PCR Analyzer for Detection of Pathogen's related to Women's Health and Sexual Healthview on SAM.gov

The Department of Veterans Affairs (VA), Network Contracting Office 20 (NCO 20), is conducting market research on behalf of the Jonathan M. Wainwright Memorial VA Medical Center to identify potential contractors capable of providing reagents and consumables for laboratory tests for the VA medical facilities and clinics. The Jonathan M. Wainwright Memorial VA Medical Center is comprised of: Jonathan M. Wainwright Memorial VA Medical Center. La Grande VA Clinic. Lewiston VA Clinic. Morrow County VA Clinic. Richland VA Clinic Yakima Valley VA Clinic To be considered a responsive and potential source, interested parties shall provide a capabilities statement containing the following information: Business name, address, point of contact, phone number and email address. Business size, type, and SAM Unique Identifier Number Affirmation that the vendor can provide the supplies in accordance with the attached Salient Characteristics. Additionally, contractors can provide feedback on the attached Requirements Description, which may be considered if a solicitation is posted. Provide the requested information to Hector Gonzalez at hector.gonzalez1@va.gov before 10:00 AM PST on July 21st, 2026. All questions must be submitted in writing, no telephonic inquiries will be accepted. This is a sources-sought notice only. The purpose of this notice is to obtain information regarding the availability and capability of verified sources to include qualified SDVOSB/VOSB to perform this potential requirement. Responses received will assist the Government in determining the appropriate acquisition strategy. The Government may or may not issue a solicitation as a result of this notice. There is no solicitation available at this time, and this is not a request for quotes. Salient Characteristics Molecular PCR Analyzer for Detection of Pathogen s related to Women s Health and Sexual Health Overview: The Women s Health Innovation and Staffing Enhancements (WHISE) initiative awarded funding to the Jonathan M. Wainwright Memorial VA Medical Center (VAWW) Laboratory to support implementation of in-house molecular testing capability during Fiscal Year 2026 for prompt detection and reporting of pathogens related to veteran women s health and sexual health. Scope Required for Women s Health and Sexual Health Testing: The analyzer must allow for rapid in-house molecular testing with significantly improved turnaround times of 1.0 -1.5 hours (or less) for women s health and sexual health to support same-day diagnosis and treatment workflows when clinically appropriate. Must have the ability to perform Multiplex Vaginal Panel and Chlamydia trachomatis/Neisseria gonorrhoeae on a single platform (instrument) simultaneously. These two panels include: Multiplex Vaginal Panel (results in 60 minutes or less) Bacterial vaginosis Atopobium spp. Bacterial Vaginosis-Associated Bacterium (BVAB2) Megasphaera-1 Candida spp. (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis Candida glab…